Skip to main content

Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections

  • Chapter
  • First Online:
Fungal Biofilms and related infections

Part of the book series: Advances in Experimental Medicine and Biology ((AMIDPH,volume 931))

Abstract

Fungal biofilm related infections are commonly associated with medical devices with biofilms contributing to the virulence of the involved fungal species. If infection does occur, removal of medical device is often warranted. However, this is not always possible. Moreover, biofilm associated infections are often resistant to antifungals and host immunity. Therefore, a need for new agents and strategies to combat these devastating infections is needed. Although no randomized clinical trials have been conducted or are likely to be conducted in the future, the Infectious Disease Society of America (IDSA) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) utilized available published data and clinical experience of the infectious disease community to propose strategies to treat biofilm associated devise infections. In this chapter we describe the emerging therapies for biofilm related infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54(8):1110–1122, doi:cis021 [pii] 10.1093/cid/cis021

    Article  CAS  PubMed  Google Scholar 

  • Bamford NC, Snarr BD, Gravelat FN, Little DJ, Lee MJ, Zacharias CA, Chabot JC, Geller AM, Baptista SD, Baker P, Robinson H, Howell PL, Sheppard DC (2015) Sph3 is a glycoside hydrolase required for the biosynthesis of galactosaminogalactan in Aspergillus fumigatus. J Biol Chem 13:27438–27450, doi:M115.679050 [pii] 10.1074/jbc.M115.679050

    Google Scholar 

  • Beaussart A, El-Kirat-Chatel S, Fontaine T, Latge JP, Dufrene YF (2015) Nanoscale biophysical properties of the cell surface galactosaminogalactan from the fungal pathogen Aspergillus fumigatus. Nanoscale 7(36):14996–15004. doi:10.1039/c5nr04399a

    Article  CAS  PubMed  Google Scholar 

  • Beauvais A, Latge JP (2015) Aspergillus biofilm in vitro and in vivo. Microbiol Spectr 3(4):0017. doi:10.1128/microbiolspec.MB-0017-2015

    Article  Google Scholar 

  • Brand A, Gow NA (2009) Mechanisms of hypha orientation of fungi. Curr Opin Microbiol 12(4):350–357, doi:S1369-5274(09)00056-3 [pii] 10.1016/j.mib.2009.05.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Briard B, Bomme P, Lechner BE, Mislin GL, Lair V, Prevost MC, Latge JP, Haas H, Beauvais A (2015) Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines. Sci Rep 5:8220, doi:srep08220 [pii] 10.1038/srep08220

    Article  PubMed  Google Scholar 

  • Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA (2001) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80(3):903–908

    Article  CAS  PubMed  Google Scholar 

  • Chavez-Dozal AA, Jahng M, Rane HS, Asare K, Kulkarny VV, Bernardo SM, Lee SA (2014) In vitro analysis of flufenamic acid activity against Candida albicans biofilms. Int J Antimicrob Agents 43(1):86–91, doi:S0924-8579(13)00319-1 [pii] 10.1016/j.ijantimicag.2013.08.018

    Article  CAS  PubMed  Google Scholar 

  • Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Florl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–37. doi:10.1111/1469-0691.12039, S1198-743X(14)60765-5 [pii]

    Article  CAS  PubMed  Google Scholar 

  • Cuervo G, Garcia-Vidal C, Nucci M, Puchades F, Fernandez-Ruiz M, Mykietiuk A, Manzur A, Gudiol C, Peman J, Viasus D, Ayats J, Carratala J (2013) Effect of statin use on outcomes of adults with candidemia. PLoS ONE 8(10):e77317. doi:10.1371/journal.pone.0077317, PONE-D-13-16110 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ehrlich G, Hu F, Post C (2004) Biofilms in infectious disease. In: Ghannoum M, O’Toole G (eds) Microbial biofilms. ASM Press, Washington, DC, pp 269–293

    Google Scholar 

  • Fanning S, Mitchell AP (2012) Fungal biofilms. PLoS Pathog 8(4):e1002585. doi:10.1371/journal.ppat.1002585, PPATHOGENS-D-11-02842 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao L, Sun Y (2015) In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. Antimicrob Agents Chemother 59:7097–7099, doi:AAC.01510-15 [pii] 10.1128/AAC.01510-15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, D’Enfert C (2004) Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 3(2):536–545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA (2002a) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70(2):878–888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA (2002b) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46(6):1773–1780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • LaFleur MD, Lucumi E, Napper AD, Diamond SL, Lewis K (2011) Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. J Antimicrob Chemother 66(4):820–826, doi:dkq530 [pii] 10.1093/jac/dkq530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lopez-Ribot JL (2014) Large-scale biochemical profiling of the Candida albicans biofilm matrix: new compositional, structural, and functional insights. mBio 5(5):e01781-14, doi:mBio.01781-14 [pii] 10.1128/mBio.01781-14

    Article  PubMed  PubMed Central  Google Scholar 

  • Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4(2):119–128, doi:22913 [pii] 10.4161/viru.22913

    Article  PubMed  PubMed Central  Google Scholar 

  • Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71(8):4333–4340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J, Agabian NM (2005) Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot Cell 4(9):1562–1573, doi:4/9/1562 [pii] 10.1128/EC.4.9.1562-1573.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nett JE, Lepak AJ, Marchillo K, Andes DR (2009) Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis 200(2):307–313. doi:10.1086/599838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nobile CJ, Johnson AD (2015) Candida albicans biofilms and human disease. Annu Rev Microbiol 69:71–92. doi:10.1146/annurev-micro-091014-104330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, Kovanda L, Lortholary O (2010) Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 51(3):295–303. doi:10.1086/653935

    Article  PubMed  Google Scholar 

  • Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48(5):503–535. doi:10.1086/596757 [pii]

    Article  CAS  PubMed  Google Scholar 

  • Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20(1):133–163, doi:20/1/133 [pii] 10.1128/CMR.00029-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Purevdorj-Gage L, Stoodley P (2004) Biofilm structure, behavior, and hydrodynamics. In: Ghannoum M, O’Toole G (eds) Microbial biofilms. ASM Press, Washington, DC, pp 160–173

    Chapter  Google Scholar 

  • Qu Y, Locock K, Verma-Gaur J, Hay ID, Meagher L, Traven A (2015) Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms. J Antimicrob Chemother 71:413–421, doi:dkv334 [pii] 10.1093/jac/dkv334

    Article  PubMed  Google Scholar 

  • Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, Mohamed S, Ghannoum MA (2004) Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48(5):1727–1732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shah AH, Singh A, Dhamgaye S, Chauhan N, Vandeputte P, Suneetha KJ, Kaur R, Mukherjee PK, Chandra J, Ghannoum MA, Sanglard D, Goswami SK, Prasad R (2014) Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans. Biochem J 460(2):223–235, doi:BJ20140010 [pii] 10.1042/BJ20140010

    Article  CAS  PubMed  Google Scholar 

  • Srinivasan A, Gupta CM, Agrawal CM, Leung KP, Lopez-Ribot JL, Ramasubramanian AK (2014) Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms. Biotechnol Bioeng 111(2):418–424. doi:10.1002/bit.25120

    Article  CAS  PubMed  Google Scholar 

  • Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8(8):e1002848. doi:10.1371/journal.ppat.1002848, PONE-D-11-08927 [pii]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thomas J, Ramage G, Lopez-Ribot JL (2004) Biofilms and implant infections. In: Ghannoum M, O’Toole G (eds) Microbial biofilms. ASM Press, Washington, DC

    Google Scholar 

  • Trautner BW, Darouiche RO (2004) Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 164(8):842–850. doi:10.1001/archinte.164.8.842, 164/8/842 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  • van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekotter A, Lass-Florl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE (2015) Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis 21(6):1041–1044. doi:10.3201/eid2106.140717

    Article  PubMed  PubMed Central  Google Scholar 

  • Vila TV, Chaturvedi AK, Rozental S, Lopez-Ribot JL (2015) Characterization of the in vitro activity of Miltefosine against Candida albicans under planktonic and biofilm growing conditions and in vivo efficacy in the murine model of oral candidiasis. Antimicrob Agents Chemother 59:7611–7620, doi:AAC.01890-15 [pii] 10.1128/AAC.01890-15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE, Mitchell AP, Andes DR (2014) Novel entries in a fungal biofilm matrix encyclopedia. mBio 5(4):e01333-14, doi:mBio.01333-14 [pii] 10.1128/mBio.01333-14

    Article  PubMed  PubMed Central  Google Scholar 

  • Zumbuehl A, Ferreira L, Kuhn D, Astashkina A, Long L, Yeo Y, Iaconis T, Ghannoum M, Fink GR, Langer R, Kohane DS (2007) Antifungal hydrogels. Proc Natl Acad Sci U S A 104(32):12994–12998, doi:0705250104 [pii] 10.1073/pnas.0705250104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mahmoud Ghannoum .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Muakkassa, F.K., Ghannoum, M. (2016). Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections. In: Imbert, C. (eds) Fungal Biofilms and related infections. Advances in Experimental Medicine and Biology(), vol 931. Springer, Cham. https://doi.org/10.1007/5584_2016_11

Download citation

Publish with us

Policies and ethics